<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21377" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Estradiol</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hariri</surname>
            <given-names>Lana</given-names>
          </name>
          <aff>American University of The Caribbean</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rehman</surname>
            <given-names>Anis</given-names>
          </name>
          <aff>District Endocrine/Sentara Northern Virginia Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Lana Hariri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anis Rehman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21377.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Estradiol is a medication used to manage and treat postmenopausal symptoms and for women who have had hysterectomies. Estradiol is the most potent estrogen (E2) in the human body. Postmenopausal symptoms include, but are not limited to: vaginal dryness, itchiness, dysuria, and many more. This activity reviews the mechanism of action, risks, benefits, indications, contradictions, side effects, and other critical elements of estradiol therapy.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the pathophysiology of estradiol.</p></list-item><list-item><p>Summarize the administration of estradiol.</p></list-item><list-item><p>Identify the contraindications of estradiol therapy.</p></list-item><list-item><p>Explain the importance of care amongst the interprofessional team to enhance the quality of life in postmenopausal women.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21377&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21377">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21377.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Estradiol is a hormone made naturally in the human body by the ovaries. It is crucial in regulating the menstrual cycle, cardiovascular system, neurologic system, skeletal system, vascular system, and many more.<xref ref-type="bibr" rid="article-21377.r1">[1]</xref>&#x000a0;Estradiol is the most potent and abundant estrogen (E2) during a woman's reproductive years. There are four different kinds of estrogen: estrone (E1), estradiol (E2), estriol (E3), and estetrol (E4).<xref ref-type="bibr" rid="article-21377.r2">[2]</xref></p>
        <p>When women enter menopause, estrogen&#x000a0;synthesis significantly decreases due to lower-functioning ovaries. The decrease in estrogen is the reason most women have postmenopausal symptoms.&#x000a0;Postmenopausal symptoms include but are not limited to hot flashes, vaginal dryness, vaginal itchiness, dysuria, and dyspareunia. These symptoms can be very discomforting to patients and affect the quality of life, sleep, mood, interpersonal relationships, daily activities, and sexual function. When the ovaries&#x000a0;no longer&#x000a0;synthesize estradiol, it can then get synthesized by several extragonadal sites.<xref ref-type="bibr" rid="article-21377.r3">[3]</xref>&#x000a0;These sites include adipose tissue, bones, brain, and smooth muscle cells in vascular endothelium, as well as others.&#x000a0;</p>
        <p>Before women enter menopause, estradiol protects women from&#x000a0;cardiovascular&#x000a0;disease due to increased regulation of cholesterol and triglyceride metabolism, thus decreasing the risk for atherosclerotic heart disease.<xref ref-type="bibr" rid="article-21377.r4">[4]</xref>&#x000a0;To combat these symptoms, estradiol can be taken supplementally to manage and treat postmenopausal symptoms and for women who have had hysterectomies, salpingo-oophorectomy, or unilateral salpingo-oophorectomy. Estrogen is also useful in female patients with hypoestrogenism due to castration, hypogonadism, or primary ovarian failure, such as Turner syndrome.&#x000a0;</p>
        <p>The majority of studies find that postmenopausal symptoms experience significant improvement with the use of estradiol hormone replacement therapy (HRT). Also, research has shown that estradiol can decrease stress by reducing the release of cortisol in response to a physical stressor. Estradiol increases the amount of corticosteroid-binding globulin (CBG), thus reducing the free cortisol levels circulating in the body, responding to stress. Less cortisol can act on the body, including areas in the brain that are integral to the stress response.<xref ref-type="bibr" rid="article-21377.r5">[5]</xref></p>
        <p>Estrogen formulations have also served as an off-label treatment option for male-to-female transgender patients. However, the levels of blood estrogen levels require close monitoring to avoid complications of the treatment.&#x000a0;</p>
        <p>Estrogen has a significant role in bone health. Women in postmenopausal age develop osteoporosis due to decreased levels of estrogen. Estrogen-derived formulations such as raloxifene have received approval for osteoporosis prevention and treatment in a selected patient population.&#x000a0;</p>
      </sec>
      <sec id="article-21377.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Estrone is converted to estradiol in the granulosa cells of the ovary by the enzyme 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD).<xref ref-type="bibr" rid="article-21377.r2">[2]</xref>&#x000a0;The aromatization of testosterone synthesizes estradiol. Estradiol is a steroid hormone and, therefore, can easily cross the cell membrane. Estrone binds to its specific intracellular receptor and regulates DNA transcription for protein formation.<xref ref-type="bibr" rid="article-21377.r2">[2]</xref>&#x000a0;Estrone exerts its effects on the menstrual cycle, breasts, ovaries, brain, musculoskeletal system, cardiovascular system, and more. Estrone appears to affect the gene transcription of other genes that do not have estrogen-responsive elements.</p>
      </sec>
      <sec id="article-21377.s4" sec-type="Administration">
        <title>Administration</title>
        <p>Hormone replacement therapy (HRT) is normally used for a short period in post-menopausal women. The routes of admission can be transdermal (cream and patches), intramuscular, or oral.&#x000a0;Estradiol therapy usually comes in two forms: as a vaginal cream or as a capsule. Studies have found that using estradiol vaginal cream twice a week has significantly reduced vaginal dryness and dyspareunia compared to placebo pills. However, there was no significant improvement between estradiol vaginal cream and placebo therapy in vaginal irritation, itchiness, and dysuria.<xref ref-type="bibr" rid="article-21377.r6">[6]</xref></p>
        <p>There is still research underway to determine the efficacy of vaginal estradiol capsules. Capsules currently undergoing clinical trials hope to relieve post-menopausal symptoms with very little systemic estradiol exposure. The capsules should be less messy and more patient-friendly than creams and tablets.<xref ref-type="bibr" rid="article-21377.r7">[7]</xref></p>
        <p>In one clinical trial, capsules improved vaginal dryness and dyspareunia. Also, capsules increased the percentage of superficial and intermediate cells in the vagina, thus improving vaginal physiology.</p>
        <p>Sustained-release estradiol vaginal rings are becoming more popular in research. Rings can be effective for up to 90 days and can be easily inserted and removed by patients.<xref ref-type="bibr" rid="article-21377.r8">[8]</xref>&#x000a0;The ring may be beneficial to women who choose not to apply vaginal estrogen creams.&#x000a0;</p>
      </sec>
      <sec id="article-21377.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Adverse effects are generally uncommon; however, there have been reports of the following:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiovascular: edema, hypertension, thrombophlebitis, retinal thrombosis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Central Nervous System: headache, depression, pain, dizziness, anxiety, migraine, nipple pain</p>
          </list-item>
          <list-item>
            <p>Respiratory: nasopharyngitis, flu-like symptoms, sinusitis, upper respiratory tract infection, headache, bronchitis, sinus congestion, pharyngitis, asthma exacerbation, cough&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Dermatologic: skin rash, pruritus, erythema multiforme, erythema nodosum, urticaria</p>
          </list-item>
          <list-item>
            <p>Skeletal: arthralgia, weakness, back and neck pain, limb pain, myalgia, leg cramps</p>
          </list-item>
          <list-item>
            <p>Endocrine: weight gain or loss, hot flash, libido changes, hirsutism, menstrual changes, porphyria exacerbation, fluid retention, hypocalcemia, elevated triglycerides, galactorrhea</p>
          </list-item>
          <list-item>
            <p>Gastrointestinal: Abdominal pain, constipation, heartburn, flatulence, bloating, nausea, vomiting, diarrhea, pancreatitis, gastroenteritis, carbohydrate intolerance&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hypersensitivity: anaphylaxis, angioedema, hypersensitivity reactions</p>
          </list-item>
          <list-item>
            <p>Hepatic: Hepatic hemangioma exacerbation, jaundice</p>
          </list-item>
          <list-item>
            <p>Ophthalmic: conjunctivitis, steepening of the cornea, contact lens intolerance&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Infections: fungal and other infections</p>
          </list-item>
          <list-item>
            <p>Otic: Otitis media&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>The United States Food and Drug Administration (FDA) Boxed Warnings</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Women who take estrogen plus progestin therapy are at increased risk for breast cancer.</p>
          </list-item>
          <list-item>
            <p>Women with increased exposure to estrogen are at risk for endometrial cancer. Estrogen stimulates endometrial growth, which results in endometrial hyperplasia, which could result in endometrial cancer.</p>
          </list-item>
          <list-item>
            <p>Other risk factors associated with increased exposure to estrogen HRT are cerebrovascular events, coronary artery disease, and venous thromboembolism.<xref ref-type="bibr" rid="article-21377.r9">[9]</xref> There have also been reports of ovarian cancer with estrogen use.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>An estradiol patch has a boxed warning for probable dementia.&#x000a0;The Women's Health Initiative study found that postmenopausal women 65 and older who took oral conjugated estrogens with medroxyprogesterone acetate for four years had an increased risk of developing probable dementia compared to a placebo.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21377.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Women who are at increased risk of breast cancer or endometrial cancer should not begin Estradiol therapy.</p>
        <p>Overweight women with exposure to increased estradiol levels in their lifetime should not add supplemental estradiol to their post-menopause regimen.<xref ref-type="bibr" rid="article-21377.r10">[10]</xref>&#x000a0;Adipose tissue carries an increased level of estrogen. Therefore overweight women are at risk of increased exposure compared to average-weight and underweight women.&#x000a0;</p>
        <p>Women who have angioedema or anaphylactic reaction to estradiol or its components, abnormal genital bleeding, blood clotting&#x000a0;disorders such as deep venous thrombosis or pulmonary thromboembolism, cardiovascular disease (a stroke or myocardial infarction), protein C or S&#x000a0; or antithrombin deficiency, as well as thrombophilic disorders, or pregnancy, are contraindications to estradiol treatment.&#x000a0;</p>
        <p>Estradiol HRT can increase a patient's risk of cardiovascular disease, DVT, and stroke and, therefore, is not a viable option in at-risk patients.&#x000a0;&#x000a0;</p>
        <p>Women at risk can consider other alternatives such as laser therapy, lubricants, dilators, and even physical therapy to strengthen pelvic floor muscles if patients complain of dyspareunia.<xref ref-type="bibr" rid="article-21377.r8">[8]</xref></p>
      </sec>
      <sec id="article-21377.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>There is not much monitoring for estradiol therapy for women who choose to use vaginal creams or capsules. However, women who choose to use the high-dose estradiol vaginal ring should understand the risks due to increased estradiol in systemic circulation.&#x000a0;</p>
        <p>If a woman&#x000a0;is at risk of developing endometrial cancer and chooses to undergo estradiol HRT, she should continually undergo endometrial monitoring.&#x000a0;</p>
        <p>Levels of estrogen are monitored in transgender patients and maintained according to Endocrine Society guidelines.&#x000a0;</p>
      </sec>
      <sec id="article-21377.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>There are no published reports of estradiol toxicity in humans. However, one study measured estradiol toxicity in amphibians' embryos.<xref ref-type="bibr" rid="article-21377.r11">[11]</xref> Research determined that&#x000a0;estradiol toxicity occurred when the amount of estradiol severely outnumbered estradiol receptors; this was an incredibly high number that would be highly unlikely in a human population. Estradiol excess may lead to side effects and complications noted in the adverse effect section.</p>
      </sec>
      <sec id="article-21377.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Educating women about the physiology behind post-menopausal symptoms is essential so that they can understand the changes that occur with decreased estrogen. Many women are embarrassed and shy to talk about this topic. Primary care clinicians and obstetricians-gynecologists should&#x000a0;ask and encourage women to talk about their symptoms. Providers&#x000a0;will better be able to offer advice, tips, and education, as indicated.</p>
        <p>An interprofessional healthcare team approach is the optimal path to follow when initiating or considering initiating estradiol therapy. The family clinician and gynecologist should coordinate their efforts. A pharmacist should review the patient's medication record, verify that dosing is appropriate, and counsel the patient regarding potential adverse effects to report these to the prescriber should they present. Nursing must also assist the team by counseling the patient so they are aware of possible adverse events. They can also monitor the patient on follow-up visits and determine how effectively the patient responds to treatment. This interprofessional team paradigm optimizes treatment and avoids adverse events, thereby improving patient outcomes. [Level 5]</p>
      </sec>
      <sec id="article-21377.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21377&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21377">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21377/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21377">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21377.s11">
        <title>References</title>
        <ref id="article-21377.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mauvais-Jarvis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Clegg</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Hevener</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>The role of estrogens in control of energy balance and glucose homeostasis.</article-title>
            <source>Endocr Rev</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>309</fpage>
            <page-range>309-38</page-range>
            <pub-id pub-id-type="pmid">23460719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21377.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Potter</surname>
                <given-names>BV</given-names>
              </name>
            </person-group>
            <article-title>The structural biology of oestrogen metabolism.</article-title>
            <source>J Steroid Biochem Mol Biol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>137</volume>
            <fpage>27</fpage>
            <page-range>27-49</page-range>
            <pub-id pub-id-type="pmid">23291110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21377.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simpson</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Sources of estrogen and their importance.</article-title>
            <source>J Steroid Biochem Mol Biol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>86</volume>
            <issue>3-5</issue>
            <fpage>225</fpage>
            <page-range>225-30</page-range>
            <pub-id pub-id-type="pmid">14623515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21377.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palmisano</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stafford</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Role of Estrogens in the Regulation of Liver Lipid Metabolism.</article-title>
            <source>Adv Exp Med Biol</source>
            <year>2017</year>
            <volume>1043</volume>
            <fpage>227</fpage>
            <page-range>227-256</page-range>
            <pub-id pub-id-type="pmid">29224098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21377.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herrera</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Hodis</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Mather</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Estradiol Therapy After Menopause Mitigates Effects of Stress on Cortisol and Working Memory.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2017</year>
            <month>Dec</month>
            <day>01</day>
            <volume>102</volume>
            <issue>12</issue>
            <fpage>4457</fpage>
            <page-range>4457-4466</page-range>
            <pub-id pub-id-type="pmid">29106594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21377.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Archer</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Kimble</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>FDY</given-names>
              </name>
              <name>
                <surname>Battucci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sniukiene</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.</article-title>
            <source>J Womens Health (Larchmt)</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>231</fpage>
            <page-range>231-237</page-range>
            <pub-id pub-id-type="pmid">29193980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21377.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simon</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Archer</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Constantine</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Pickar</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Amadio</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bernick</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mirkin</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data review.</article-title>
            <source>Maturitas</source>
            <year>2017</year>
            <month>May</month>
            <volume>99</volume>
            <fpage>51</fpage>
            <page-range>51-58</page-range>
            <pub-id pub-id-type="pmid">28364869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21377.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Faubion</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Sood</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Genitourinary Syndrome of Menopause: Management Strategies for the Clinician.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>92</volume>
            <issue>12</issue>
            <fpage>1842</fpage>
            <page-range>1842-1849</page-range>
            <pub-id pub-id-type="pmid">29202940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21377.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hill</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Crider</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Hormone Therapy and Other Treatments for Symptoms of Menopause.</article-title>
            <source>Am Fam Physician</source>
            <year>2016</year>
            <month>Dec</month>
            <day>01</day>
            <volume>94</volume>
            <issue>11</issue>
            <fpage>884</fpage>
            <page-range>884-889</page-range>
            <pub-id pub-id-type="pmid">27929271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21377.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Samavat</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kurzer</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Estrogen metabolism and breast cancer.</article-title>
            <source>Cancer Lett</source>
            <year>2015</year>
            <month>Jan</month>
            <day>28</day>
            <volume>356</volume>
            <issue>2 Pt A</issue>
            <fpage>231</fpage>
            <page-range>231-43</page-range>
            <pub-id pub-id-type="pmid">24784887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21377.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fridman</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Corr&#x000f3;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Herkovits</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Estradiol uptake, toxicity, metabolism, and adverse effects on cadmium-treated amphibian embryos.</article-title>
            <source>Environ Health Perspect</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>112</volume>
            <issue>8</issue>
            <fpage>862</fpage>
            <page-range>862-6</page-range>
            <pub-id pub-id-type="pmid">15175173</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
